These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The effects of enoximone on renal function in patients with congestive heart failure. Clifton G; McMahon G; Ryan J; Vargas R; Bekele T; Wallin D Clin Pharmacol Ther; 1989 Jan; 45(1):85-91. PubMed ID: 2521320 [TBL] [Abstract][Full Text] [Related]
28. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895 [TBL] [Abstract][Full Text] [Related]
29. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation]. Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897 [TBL] [Abstract][Full Text] [Related]
30. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation. Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874 [TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic effects of enoximone in patients with congestive heart failure. Hohnloser SH; Zehender M; Geibel A; Meinertz T; Just H J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S29-32. PubMed ID: 2480482 [TBL] [Abstract][Full Text] [Related]
32. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR; Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591 [TBL] [Abstract][Full Text] [Related]
33. [Tolerance of enoximone in patients with heart failure]. Gilfrich HJ; Dieterich HA Z Kardiol; 1991; 80 Suppl 4():93-7. PubMed ID: 1833904 [TBL] [Abstract][Full Text] [Related]
34. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure. Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580 [TBL] [Abstract][Full Text] [Related]
35. The effects of captopril on serum digoxin levels in patients with severe congestive heart failure. Kirimli O; Kalkan S; Guneri S; Tuncok Y; Akdeniz B; Ozdamar M; Guven H Int J Clin Pharmacol Ther; 2001 Jul; 39(7):311-4. PubMed ID: 11471775 [TBL] [Abstract][Full Text] [Related]
36. A dose-response study of intravenous enoximone in congestive heart failure. Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865 [TBL] [Abstract][Full Text] [Related]
37. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study. Leier CV; Lima JJ; Meiler SE; Unverferth DV Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546 [TBL] [Abstract][Full Text] [Related]
38. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure. Chatterjee K; Kereiakes D; Viquerat C; Podolin R Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866 [TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience. Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876 [TBL] [Abstract][Full Text] [Related]